Pharmaceutical compositions and methods of treatment based on VEGF antisense oligonucleotides

Details for Australian Patent Application No. 2001229254 (hide)

Owner Gill, P.

Inventors Masood, Rizwan; Gill, Parkash S

Agent FB Rice

Pub. Number AU-B-2001229254

PCT Pub. Number WO01/52904

Priority 09/487,023 19.01.00 US

Filing date 19 January 2001

Wipo publication date 31 July 2001

Acceptance publication date 27 July 2006

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

27 July 2006 Application Accepted

  Published as AU-B-2001229254

23 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001229259-Modular clean room filter system

2001229253